Lenalidomide improves the antitumor activity of CAR-T cells directed toward the intracellular Wilms Tumor 1 antigen-Reference-Cited by-同舟云学术

Lenalidomide improves the antitumor activity of CAR-T cells directed toward the intracellular Wilms Tumor 1 antigen

Published:2021-01-01 Issue:1 Volume:26 Page:818-826
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Zhang Li¹,Jin Guangyi¹,Chen Ziren¹,Yu Changhua¹,Li Yonghui²,Li Yisheng¹,Chen Jinghong¹,Yu Li¹³

Affiliation:

1. Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhen, Guangdong, People’s Republic of China

2. Central Laboratory, Shenzhen University General Hospital, Shenzhen, People’s Republic of China

3. Military General Hospital of Beijing PLA, Beijing, People’s Republic of China

Funder

Science and Technology Foundation of Shenzhen

National Science and Technology Major Project

State Key Program of National Natural Science of China

Shenzhen Key Laboratory Foundation

Sanming Project of Shenzhen

Natural Science Foundation of Shenzhen University General Hospital

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.1981534

Reference19 articles.

1. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

2. Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities

3. Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial

4. Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer immunotherapy of Wilms tumor: a narrative review;Future Oncology;2024-09-05

2. Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy;Trends in Molecular Medicine;2024-08

3. CAR-NK cells in combination therapy against cancer: A potential paradigm;Heliyon;2024-03

4. Lenalidomide improves NKG2D-based CAR-T cell activity against colorectal cancer cells invitro;Heliyon;2023-10

5. The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy;Frontiers in Immunology;2023-04-21